RecallRadar

FDA Drug recall D-1701-2012

NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, I…

On 2012-10-03 the FDA classified a Class II recall of NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, I… by Glenmark Generics Usa, citing labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1701-2012
ClassificationClass II
Statusterminated
Initiated2012-07-06
Published2012-10-03
Last updated2026-09-13 11:51 UTC
CompanyGlenmark Generics Usa
DistributionUS

Product

NAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd., Colvale-Bardez, Goa 403513, India; Manufactured for: Glenmark Generics Inc., USA, Mahwah, NJ 07430; NDC 68462-190-01.

Reason

Labeling: Label Mix-Up: Bottles labeled as Naproxen Tablets USP, 500 mg, 100-count may contain 90-count Pravastatin Sodium Tablets, 40 mg.

Identifiers

ndc68462-188-01
ndc68462-188-05
ndc68462-189-01
ndc68462-189-05
ndc68462-190-30
ndc68462-190-50
ndc68462-190-01
ndc68462-190-05
ndc68462-178-01
ndc68462-178-05
ndc68462-179-01
ndc68462-179-05
code_infoLot #: 02112930, 02112934, 02112941, Exp 09/14; 2112985, 02112986, 02113334, Exp 10/14; 02113360, 02113372, 02113420, 02113606, 02113663, 02113664, Exp 11/14.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1701-2012%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.